|D002318||Cardiovascular Diseases NIH||0.17|
There is one clinical trial.
This is a clinical trial of a cash transfer on symptoms consistent with COVID-19 and adherence to physical distancing guidance.
Description: 32-item Influenza Patient-reported Outcome (FLU-PRO) symptom score. Higher score is worse.Measure: Symptoms consisent with COVID-19 Time: 14 days
Description: Three-items (worry about food running out, food did not last, balanced meals)Measure: Food security Time: 14 days
Description: Single item: "During the last two weeks, did you or any member of your household not take a medication, skip some doses, split pills or do anything else to make a medication last longer due to the cost?"Measure: Cost-related medicine non-adherence Time: 14 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports